[ad_1]
A US pharmaceutical company has developed a small smart pill with accurate sensors that allows the doctor to follow his cancer patients, remind them of the time of taking the medication on time, provide information on their condition and to follow their level of activity.
Proteus, the first clinical trial of the smart pill in the Silicon Valley Oncology Department, is currently the focus of seven patients with advanced colorectal cancer. He uses a special version of chemical capecitabine, enclosed in a thin transparent layer with a smart microprocessor. .
[ad_2]
Proteus, the first clinical trial of the smart pill in the Silicon Valley Oncology Department, is currently the focus of seven patients with advanced colorectal cancer. He uses a special version of chemical capecitabine, enclosed in a thin transparent layer with a smart microprocessor. .
The smart chip sends information via a sticker the size of a sticker to the patient's stomach to follow the pill when it enters the digestive system, according to Business Insider.
The company explained that the smart pill also monitors the level of patient activity and transmits data to physicians in order to track patients' status and their distance development.
The company said the smart pill is currently being tested for only 7 patients, but aims to recruit 750 patients in the next two years, and to "scan" all drugs for cancer patients, including antalgics and painkillers.
Source link